American Society of Hirudotherapy

Management of venous thrombosis in fibular free osseomusculocutaneous flaps used for mandibular reconstruction: clinical techniques and treatment considerations

Case report published in Head & face medicine (2010)

Last Updated: November 1, 2026ASH Editorial · based on the books
Research article — evidence review: Off-label use means application outside the FDA-cleared indication. Clinical evidence (RCTs or systematic reviews) supports this use, but the FDA has not cleared it.Article reference: Content describes science, methodology, or organizational reference material — not a clinical efficacy claim.
Evidence: Case reportClinical LiteratureDraenert FG et al. · Head & face medicine, 2010

Abstract

BACKGROUND: Mandibular reconstruction by means of fibula transplants is the standard therapy for severe bone loss after subtotal mandibulectomy. Venous failure still represents the most common complication in free flap surgery. We present the injection of heparine into the arterial pedicle as modification of the revising both anastomoses in these cases and illustrate the application with a clinical case example. METHODS: Methods consist of immediate revision surgery with clot removal, heparin perfusion by direct injection in the arterial vessel of the pedicle, subsequent high dose low-molecular weight heparin therapy, and leeches. After 6 hours postoperatively, images of early flap recovery show first sings of recovery by fading livid skin color. RESULTS: The application of this technique in a patient with venous thrombosis resulted in the complete recovery of the flap 60 hours postoperatively. Other cases achieved similar success without additional lysis Therapy or revision of the arterial anastomosis. CONCLUSION: Rescue of fibular flaps is possible even in patients with massive thrombosis if surgical revision is done quickly.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeCase ReportsJournal Article
Indexed MeSH termsAnticoagulantsBone TransplantationFibulaHeparinHumansMaleMandibleMiddle AgedOsteotomyPlastic Surgery ProceduresReoperationSurgical FlapsTreatment OutcomeVenous Thrombosis

Summary

This report describes a salvage protocol for venous thrombosis in fibular free flaps used for mandibular reconstruction: immediate revision with clot removal, intra-arterial heparin perfusion, high-dose low-molecular-weight heparin, and leeches achieved complete flap recovery within 60 hours in the index case.

Why This Matters for Hirudotherapy

This article describes a multimodal technique for managing venous thrombosis in fibular free flaps used for mandibular reconstruction, illustrated with a clinical case. The approach combined immediate surgical revision with clot removal, heparin perfusion via direct injection into the arterial pedicle, subsequent high-dose low-molecular-weight heparin therapy, and leeches. The abstract reports that the illustrated case achieved complete flap recovery within 60 hours, and notes that other cases achieved similar success without additional lysis therapy or arterial anastomosis revision. This article is directly relevant to hirudotherapy as it documents the inclusion of medicinal leeches within a combined protocol for venous congestion in surgical flaps. However, because multiple interventions were applied concurrently, the isolated contribution of leech therapy to outcomes cannot be determined from the abstract.

Citation

Reference (Vancouver style)

Draenert FG, Gosau M, Al Nawas B. Management of venous thrombosis in fibular free osseomusculocutaneous flaps used for mandibular reconstruction: clinical techniques and treatment considerations. Head Face Med. 2010;6:8. doi:10.1186/1746-160X-6-8. PMID: 20529277

Bibliographic details (authors, volume, pages, DOI) are taken from the PubMed record.

Added to ASH library: May 27, 2026 · Site last updated: November 1, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.